|
[1]
|
Tan ZL, Chen ZX, Yu AP, Li XY, Feng YN, Zhao X, et al. The first two imported cases of SARS-CoV-2 Omicron Variant - Tianjin Municipality, China, December 13, 2021. China CDC Wkly 2022;4(4):76 − 7. http://dx.doi.org/10.46234/ccdcw2021.266CrossRef
|
|
[2]
|
Guo QF, A RH, Liang LJ, Zhao X, Deng AP, Hu Y, et al. An imported case of BA.2 lineage of omicron variant COVID-19 - Guangdong Province, China, December 28, 2021. China CDC Wkly 2022;4(5):98 − 9. http://dx.doi.org/10.46234/CCDCW2022.001.http://dx.doi.org/10.46234/CCDCW2022.001 |
|
[3]
|
Backer JA, Eggink D, Andeweg SP, Veldhuijzen IK, van Maarseveen N, Vermaas K, et al. Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021. Euro Surveill 2022;27(6):2200042. http://dx.doi.org/10.2807/1560-7917.ES.2022.27.6.2200042.http://dx.doi.org/10.2807/1560-7917.ES.2022.27.6.2200042 |
|
[4]
|
Boucau J, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, et al. Duration of viable virus shedding in SARS-CoV-2 omicron variant infection. medRxiv 2022. http://dx.doi.org/10.1101/2022.03.01.22271582.http://dx.doi.org/10.1101/2022.03.01.22271582 |
|
[5]
|
Chen TM, Rui J, Wang QP, Zhao ZY, Cui JA, Yin L. A mathematical model for simulating the phase-based transmissibility of a novel coronavirus. Infect Dis Poverty 2020;9(1):24. http://dx.doi.org/10.1186/s40249-020-00640-3CrossRef
|
|
[6]
|
Lao XY, Luo L, Lei Z, Fang T, Chen Y, Liu YH, et al. The epidemiological characteristics and effectiveness of countermeasures to contain coronavirus disease 2019 in Ningbo City, Zhejiang Province, China. Sci Rep 2021;11(1):9545. http://dx.doi.org/10.1038/s41598-021-88473-4CrossRef
|
|
[7]
|
Liu ZR, Zhao ZY, Wu JB, Rui J, Gong L, Lin SN, et al. Evaluation of transmission dynamics and control measures of COVID-19 in Anhui Province in 2020. Anhui J Prev Med 2021;27(1):1 − 5,19. http://dx.doi.org/10.19837/j.cnki.ahyf.2021.01.001 (In Chinese). CrossRef
|
|
[8]
|
Liu WK, Ye WJ, Zhao ZY, Liu C, Deng B, Luo L, et al. Modelling the emerging COVID-19 epidemic and estimating intervention effectiveness - Taiwan, China, 2021. China CDC Wkly 2021;3(34):716 − 9. http://dx.doi.org/10.46234/ccdcw2021.177CrossRef
|
|
[9]
|
Xue L, Jing SL, Zhang K, Milne R, Wang H. Infectivity versus fatality of SARS-CoV-2 mutations and influenza. Int J Infect Dis 2022;121:195 − 202. http://dx.doi.org/10.1016/j.ijid.2022.05.031CrossRef
|